PI3K-Akt Signaling Activates mTOR-Mediated Epileptogenesis in Organotypic Hippocampal Culture Model of Post-Traumatic Epilepsy

被引:80
作者
Berdichevsky, Yevgeny [1 ,2 ]
Dryer, Alexandra M. [3 ]
Saponjian, Yero [1 ]
Mahoney, Mark M. [4 ]
Pimentel, Corrin A. [4 ]
Lucini, Corrina A. [4 ]
Usenovic, Marija [1 ]
Staley, Kevin J. [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA
[2] Harvard Univ, Sch Med, Boston, MA 02129 USA
[3] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA
[4] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA
基金
美国国家卫生研究院;
关键词
TEMPORAL-LOBE EPILEPSY; MAMMALIAN TARGET; STATUS EPILEPTICUS; INTERICTAL SPIKES; BRAIN-INJURY; MOUSE MODEL; CELL-DEATH; IN-VITRO; RAPAMYCIN; SEIZURES;
D O I
10.1523/JNEUROSCI.3870-12.2013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
mTOR is activated in epilepsy, but the mechanisms of mTOR activation in post-traumatic epileptogenesis are unknown. It is also not clear whether mTOR inhibition has an anti-epileptogenic, or merely anticonvulsive effect. The rat hippocampal organotypic culture model of post-traumatic epilepsy was used to study the effects of long-term (four weeks) inhibition of signaling pathways that interact with mTOR. Ictal activity was quantified by measurement of lactate production and electrical recordings, and cell death was quantified with lactate dehydrogenase (LDH) release measurements and Nissl-stained neuron counts. Lactate and LDH measurements were well correlated with electrographic activity and neuron counts, respectively. Inhibition of PI3K and Akt prevented activation of mTOR, and was as effective as inhibition of mTOR in reducing ictal activity and cell death. A dual inhibitor of PI3K and mTOR, NVP-BEZ235, was also effective. Inhibition of mTOR with rapamycin reduced axon sprouting. Late start of rapamycin treatment was effective in reducing epileptic activity and cell death, while early termination of rapamycin treatment did not result in increased epileptic activity or cell death. The conclusions of the study are as follows: (1) the organotypic hippocampal culture model of post-traumatic epilepsy comprises a rapid assay of anti-epileptogenic and neuroprotective activities and, in this model (2) mTOR activation depends on PI3K-Akt signaling, and (3) transient inhibition of mTOR has sustained effects on epilepsy.
引用
收藏
页码:9056 / 9067
页数:12
相关论文
共 44 条
[1]   Interictal spikes, seizures and ictal cell death are not necessary for post-traumatic epileptogenesis in vitro [J].
Berdichevsky, Yevgeny ;
Dzhala, Volodymyr ;
Mail, Michelle ;
Staley, Kevin J. .
NEUROBIOLOGY OF DISEASE, 2012, 45 (02) :774-785
[2]   APOPTOSIS AND NECROSIS - 2 DISTINCT EVENTS INDUCED, RESPECTIVELY, BY MILD AND INTENSE INSULTS WITH N-METHYL-D-ASPARTATE OR NITRIC-OXIDE SUPEROXIDE IN CORTICAL CELL-CULTURES [J].
BONFOCO, E ;
KRAINC, D ;
ANKARCRONA, M ;
NICOTERA, P ;
LIPTON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7162-7166
[3]   Mammalian target of rapamycin: Biological function and target for novel anticancer agents [J].
Borders, Emily B. ;
Bivona, Cory ;
Medina, Patrick J. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (24) :2095-2106
[4]   Inhibition of the Mammalian Target of Rapamycin Signaling Pathway Suppresses Dentate Granule Cell Axon Sprouting in a Rodent Model of Temporal Lobe Epilepsy [J].
Buckmaster, Paul S. ;
Ingram, Elizabeth A. ;
Wen, Xiling .
JOURNAL OF NEUROSCIENCE, 2009, 29 (25) :8259-8269
[5]   A comprehensive map of the mTOR signaling network [J].
Caron, Etienne ;
Ghosh, Samik ;
Matsuoka, Yukiko ;
Ashton-Beaucage, Dariel ;
Therrien, Marc ;
Lemieux, Sebastien ;
Perreault, Claude ;
Roux, Philippe P. ;
Kitano, Hiroaki .
MOLECULAR SYSTEMS BIOLOGY, 2010, 6
[6]  
Castillo M, 2001, AM J NEURORADIOL, V22, P152
[7]   CEREBRAL METABOLIC CHANGES DURING PROLONGED EPILEPTIC SEIZURES IN RATS [J].
CHAPMAN, AG ;
MELDRUM, BS ;
SIESJO, BK .
JOURNAL OF NEUROCHEMISTRY, 1977, 28 (05) :1025-1035
[8]   Targeting the mTOR signaling network in cancer [J].
Chiang, Gary G. ;
Abraham, Robert T. .
TRENDS IN MOLECULAR MEDICINE, 2007, 13 (10) :433-442
[9]   Clinical application of sirolimus in renal transplantation: an update [J].
Chueh, SCJ ;
Kahan, BD .
TRANSPLANT INTERNATIONAL, 2005, 18 (03) :261-277
[10]  
Chung RS, 2003, J NEUROSCI, V23, P3336